Results 181 to 190 of about 137,068 (205)

Nonalcoholic Steatohepatitis Treatment

Gastroenterology, 2011
Micah, Luong, George K K, Lau
openaire   +2 more sources

Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies

Nature Reviews Drug Discovery, 2016
Giovanni Musso, Roberto Gambino
exaly  

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

Lancet, The, 2016
Piers Gaunt, Guruprasad P Aithal, Darren Barton   +2 more
exaly  

Steatohepatitis und Steatohepatitis-getriebener Leberkrebs

TumorDiagnostik & Therapie, 2018
openaire   +1 more source

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

Lancet, The, 2015
Brent A Neuschwander-Tetri, Rohit Loomba, Arun J Sanyal   +2 more
exaly  

NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Lancet, The, 2018
Mary E Rinella, Manal F Abdelmalek, Mustafa R Bashir   +2 more
exaly  

Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial

Lancet, The, 2018
Arun J Sanyal, Brent A Neuschwander-Tetri, Rohit Loomba   +2 more
exaly  

Metformin in non-alcoholic steatohepatitis

Lancet, The, 2001
Giulio Marchesini, Giampaolo Bianchi
exaly  

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Lancet, The, 2019
Zobair M Younossi, Vlad Ratziu, Rohit Loomba   +2 more
exaly  

The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Nature Reviews Gastroenterology and Hepatology, 2018
Konstantin Kazankov, Simon Mark Dahl Jørgensen, Karen Louise Thomsen   +2 more
exaly